Company: BCS
Filing Date: 2025-08-06
Form Type: 424B2
Source: 0001193125-25-174548
Chunk: 117

Company: BARCLAYS PLC
Filing Date: 2025-08-06
Form: 424B2
Chunk 117
---
 Remedies—No other remedies” below, include beneficial owners of the contingent capital securities.

General

The contingent capital securities are not deposit liabilities of Barclays PLC and are not insured by any regulatory body of the United States
or the United Kingdom.

Because we are a holding company, our rights to participate in the assets of any of our subsidiaries upon its
liquidation will be subject to the prior claims of the subsidiaries’ creditors, including, in the case of our bank subsidiaries, their respective depositors, except, in our case, to the extent that we may ourselves be a creditor with recognized
claims against the relevant subsidiary.

The Contingent Capital Securities Indenture does not limit the amount of contingent capital
securities that we may issue. We may issue the contingent capital securities in one or more series, or as units comprised of two or more related series. A series of contingent capital securities will be perpetual (i.e., without a maturity date).

-27-

The prospectus supplement will indicate for each series or of two or more related series of contingent capital securities:

| • |     | the issue date; |

| • |     | the maturity date, if any; |

| • |     | the specific designation and aggregate principal amount of the contingent capital securities; |

| • |     | any limit on the aggregate principal amount of the contingent capital securities that may be authenticated or 
 delivered;                                                                                                    |

| • |     | the person to whom any interest on any contingent capital security may be payable, if other than the holder on 
 the relevant record date;                                                                                      |

| • |     | whether the contingent capital securities are intended to qualify as capital for capital adequacy purposes; |

| • |     | the ranking of the contingent capital securities relative to our issued debt and equity, including to what extent                                                                      
 they may rank junior in right of payment to other of our obligations or in any other manner, if different from the relevant provisions in the Contingent Capital Securities Indenture; |

| • |     | the prices at which we will issue the contingent capital securities; |

| • |     | if interest is payable, the interest rate or rates, or how to calculate the interest rate or rates, and under 
 what circumstances interest is payable;                                                                       |

| • |     | provisions, if any, for the cancellation of any interest payment at our discretion or under other circumstances,                                       
 if different from the interest cancellation provisions and restrictions on interest payments set forth in the Contingent Capital Securities Ind